HealthTronics makes a play for Endocare
This article was originally published in Clinica
Executive Summary
Austin, Texas-based urology company HealthTronics said on Wednesday (August 6) it has sent a letter to Endocare proposing to acquire the latter for $2.28 per share in cash. The offer represents a 20% premium over the Endocare's $1.90 closing price that day.